Swati Kumar

Swati Kumar has extensive experience in the healthcare and pharmaceutical sectors, with a focus on equity research and investment banking. Currently serving as a Therapeutics Strategist at Guidepoint since October 2018, Swati has previously held positions at Evercore in Healthcare M&A Investment Banking, Guggenheim Securities as Vice President of Equity Research for Specialty Pharma, and Leerink Swann as Vice President of Equity Research for Large Cap Pharma. Additional roles include Senior Equity Research Associate at Collins Stewart and Business Development Manager at LSK Biopartners. Early career experience includes positions as an Equity Research Associate at Susquehanna International Group and C.E. Unterberg, Towbin. Swati holds Bachelor of Arts degrees in Biological Sciences from Barnard College and Columbia University, both earned from 2001 to 2005.